EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development‐based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction

Wenchao Zhang, Kai Dai, Tong Shen, Zehua Gao, Fengying Yan, Yuke Feng, Xuanlin Wang, Shaozhen Zhang, Jing Wang iD, Changsheng Liu

Advanced Science · 2026

DOI: 10.1002/advs.202522408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Wenchao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Bioreactors, Tissue Engineering, Aging, Bone Regeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Center Program, National Natural Science Foundation of China, Foundation of Frontiers Science Center for Materiobiology and Dynamic Chemistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical segmental bone defects in elderly patients pose a formidable clinical challenge due to limited autograft availability, senescent bone dysfunction, and compromised healing from fibrous tissue invasion. Here, we present a development‐based in vivo bioreactor strategy wherein BMP‐2‐loaded biomaterials trigger the body's intrinsic developmental programs, using the organism as a bioreactor to engineer bone. Distinct from classical developmental engineering, this in vivo bioreactor‐derived bone (vBR‐Bone) recapitulates native osseous architecture, including vasculature, cortical bone, trabeculae, and bone marrow niche. In aged murine models, the vBR‐Bone exhibits a rejuvenated restoration of bone bioactivity lost in aging, with reduced senescence, elevated remodeling, and improved stem cell functionality. Capitalizing on its restored remodeling capacity of high bone turnover, the vBR‐Bone fragments enclosed in an asymmetric biomimetic periosteum achieved 6‐week repair of critical‐sized 1/3 femoral shaft segmental defects. Through a “compartmentalized” approach that partitions the defect into manageable fragments, vBR‐Bone progressively remodeled and integrated into functional trabecular bone, ultimately restoring bone mineral density, volume, and microstructure in defects of aged mice. The biomimetic periosteum inhibits fibrous invasion while permitting vascular ingrowth, thereby creating a space for regeneration. Mechanistically, the multifactors within vBR‐Bone reconstitute a bone‐remodeling microenvironment, wherein matrix‐released TGF‐β1 activates the PI3K/AKT/mTOR signaling axis via TRAF6‐dependent ubiquitylation to promote robust osteogenesis. This strategy overcomes autograft shortage and senescence‐associated dysfunction, offering a clinically translatable solution for critical age‐related segmental bone defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioreactorsTissue EngineeringAgingBone RegenerationAnimalsMiceOsteogenesisHumansBone Morphogenetic Protein 2

Stichwörter der Autor:innen

agingdevelopmental engineeringin vivo bioreactorsegmental bone defect

Substanzen

Bone Morphogenetic Protein 2

Autor:innen und Institutionen

  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
  • Engineering Research Center for Biomedical Materials of the Ministry of Education, East China University of Science and Technology, Shanghai, China.
  • Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, Shanghai, China.
  • Key Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology, Shanghai, China.

ORCID-Profile: Jing Wang

Förderung

  • Basic Science Center Program
  • National Natural Science Foundation of China
  • Foundation of Frontiers Science Center for Materiobiology and Dynamic Chemistry
  • Key Research and Development Plan of Shandong Province
  • Foundation of National Center for Translational Medicine (Shanghai) SHU Branch
  • Key Technology Research and Development Program of Shandong Province

Zitieren

APA

Zhang, W., Dai, K., Shen, T., Gao, Z., Yan, F., Feng, Y., Wang, X., Zhang, S., Wang, J., & Liu, C. (2026). Development‐based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction. Advanced Science. https://doi.org/10.1002/advs.202522408

Vancouver

Zhang W, Dai K, Shen T, Gao Z, Yan F, Feng Y, et al. Development‐based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction. Advanced Science. 2026. doi:10.1002/advs.202522408

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenchao and Dai, Kai and Shen, Tong and Gao, Zehua and Yan, Fengying and Feng, Yuke and Wang, Xuanlin and Zhang, Shaozhen and Wang, Jing and Liu, Changsheng},
  title = {Development‐based In Vivo Bioreactor Strategy for Challenging Senescent Bone Reconstruction},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202522408}
}
Kostenlos starten →